40 results
Page 2 of 2
8-K
EX-99.1
c2c0oml6dyrxu
6 May 20
Cassava Sciences Reports First Quarter 2020 Financial Results and Provides Business Update
8:16am
8-K
EX-99.1
mcr6y
26 Mar 20
Cassava Sciences Announces Full-year 2019 Financial Results and Anticipated Key Milestones for 2020
8:17am
8-K
EX-99.2
q2f2bf4 cjen3m625
6 Dec 19
Regulation FD Disclosure
4:40pm
8-K
EX-99.1
af05b13b eesvo
29 Oct 19
Cassava Sciences Announces Recent Clinical Highlights and Third Quarter 2019 Financial Results
8:29am
8-K
EX-99.1
1pq0f ni2i06
9 Sep 19
Cassava Sciences Reports Positive Phase 2a Clinical Results in Alzheimer’s Patients
7:45am
8-K
EX-99.1
onnrzgr8j bfemakw
12 Aug 19
Cassava Sciences Announces Second Quarter 2019 Financial Results
3:05pm
8-K
EX-99.1
xgk6xx
29 Apr 19
Cassava Sciences Reports First Quarter 2019 Financial Results
8:45am
8-K
EX-99.1
sr9 q1clfi61xd8mkp
27 Mar 19
Pain Therapeutics Announces Name Change to
3:02pm
8-K
EX-99.1
sxz1t6czsh td3rmzt2n
25 Mar 19
Pain Therapeutics Reports 2018 Financial Results and Corporate Update
12:00am
8-K
EX-99.1
kzc6100m
29 Oct 18
Pain Therapeutics Reports Third Quarter 2018 Financial Results
4:06pm
8-K
EX-99.1
0ghiu5axrvq birj9ro9
11 Oct 18
Pain Therapeutics Announces Appointment of
4:12pm
8-K
EX-99.1
e45e43k1as63
5 Feb 07
Results of Operations and Financial Condition
12:00am